Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic Umbilical Cord Derived Mesenchymal Stem Cell Treatment in Patients With Rotator Cuff Disease
NCT06794294Phase 2Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic umbilical cord-derived mesenchymal stem cells in rotator cuff disease, sponsored by Seoul National University Hospital. Started Jan 2025; status: recruiting.
02
Drugs
allogeneic umbilical cord-derived mesenchymal stem cells
03
Conditions
rotator cuff disease
Beyond the preview
Go deeper on NCT06794294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06794294.